Related Experiment Video
Updated: Aug 18, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Commentary on androgen deficiency in women and the FDA advisory board's recent decision to request more safety data
1Center for Sexual Function, Lahey Clinic, Peabody, MA 1960, USA. Andre.T.Guay@lahey.org
Abstract:
Editor's note: The FDA's decision regarding Intrinsa has potential widespread implications for the medical treatment of female sexual dysfunction (FSD). Dr Andre Guay is a world-renowned authority on the topic of female sexuality and FSD. Accompanying Dr Spark's perspective in issue 2, this perspective will shed important light on the topic and offer insight into the past, present and future of FSD.
Related Concept Videos
Hormonal Regulation
Hormonal Regulation
Drug Regulation
Regulation of Hormone Secretion
Humoral stimuli,...
FDA Approved Drugs: Changes to Approved Drugs
Hormones of the Adrenal Glands
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...

